Thalidomide in refractory and relapsing multiple myeloma

被引：28
|
作者：
Bladé, J [1 ]
Esteve, J [1 ]
Rosiñol, L [1 ]
Perales, M [1 ]
Montoto, S [1 ]
Tuset, M [1 ]
Montserrat, E [1 ]
机构：
[1] Univ Barcelona, Hosp Clin,IDIBAPS, Hematol Dept,Pharm Serv,Inst Invest Biomed August, Inst Hematol & Oncol,Postgrad Sch Hematol Farrera, Barcelona 08036, Spain
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期
关键词：
D O I：
10.1043/sonc.2001.28610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：588 / 592
页数：5
相关论文
共 50 条
  • [21] Thalidomide in multiple myeloma
    Rajkumar, SV
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 11 - 16
  • [22] LENALIDOMIDE, MELPHALAN, PREDNISONE AND THALIDOMIDE (RMPT) FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Palumbo, A.
    Falco, P.
    Sanpaolo, G.
    Falcone, A.
    Ferderico, V.
    Canepa, L.
    Crugnola, M.
    Baldini, L.
    Caltagirone, S.
    Larocca, A.
    Gay, F.
    Magarotto, V.
    Petrucci, M. T.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 256 - 256
  • [23] Thalidomide in multiple myeloma
    Richardson, P
    Hideshima, T
    Anderson, K
    BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (03) : 115 - 128
  • [24] Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
    Tosi, P
    Zamagni, E
    Cellini, C
    Ronconi, S
    Patriarca, F
    Ballerini, F
    Musto, P
    Di Raimondo, F
    Ledda, A
    Lauria, F
    Masini, L
    Gobbi, M
    Vacca, A
    Ria, R
    Cangini, D
    Tura, S
    Baccarani, M
    Cavo, M
    HAEMATOLOGICA, 2002, 87 (04) : 408 - 414
  • [25] Thalidomide plus melphalan in relapsed-refractory multiple myeloma.
    Offidani, M
    Mele, A
    Marconi, M
    Corvatta, L
    Candela, M
    Pieroni, S
    Malerba, L
    Rupoli, S
    Olivieri, A
    Leoni, P
    BLOOD, 2001, 98 (11) : 311B - 311B
  • [26] Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma
    Srkalovic, G
    Elson, P
    Trebisky, B
    Karam, MA
    Hussein, MA
    MEDICAL ONCOLOGY, 2002, 19 (04) : 219 - 226
  • [27] Melphalan, thalidomide and decadron (MTD) for refractory/relapsed multiple myeloma (MM).
    Srkalovic, G
    Karam, MA
    McLain, DA
    Hussein, MA
    BLOOD, 1999, 94 (10) : 314B - 315B
  • [28] Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma
    Palumbo, A.
    Larocca, A.
    Falco, P.
    Sanpaolo, G.
    Falcone, A. P.
    Federico, V.
    Canepa, L.
    Crugnola, M.
    Genuardi, M.
    Magarotto, V.
    Petrucci, M. T.
    Boccadoro, M.
    LEUKEMIA, 2010, 24 (05) : 1037 - 1042
  • [29] Thalidomide is effective in the treatment of recurrent. Refractory multiple myeloma (MM).
    Sabir, T
    Raza, S
    Anderson, L
    Jagannath, S
    BLOOD, 1999, 94 (10) : 125A - 125A
  • [30] Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma
    Ochiai, N
    Yamada, N
    Uchida, R
    Fuchida, S
    Okano, A
    Hatsuse, M
    Okamoto, M
    Ashihara, E
    Shimazaki, C
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (03) : 243 - 247
12345